Skip to content
Adaptive

Learn Health Economics

Read the notes, then try the practice. It adapts as you go.When you're ready.

Session Length

~17 min

Adaptive Checks

15 questions

Transfer Probes

8

Lesson Notes

Health economics is a branch of economics that studies how scarce resources are allocated in the production, distribution, and consumption of health and healthcare. It applies economic theory, models, and empirical techniques to analyze the behavior of individuals, healthcare providers, insurers, and governments in health-related markets. Unlike standard markets, healthcare markets are characterized by pervasive information asymmetries, externalities, moral hazard, and the ethical imperative that access to care should not be determined solely by ability to pay, making health economics a uniquely complex and policy-relevant field.

Central to health economics is the evaluation of costs and outcomes associated with medical interventions, public health programs, and health system designs. Tools such as cost-effectiveness analysis, cost-benefit analysis, and quality-adjusted life years (QALYs) allow analysts to compare the value delivered by competing uses of limited healthcare budgets. These methods inform decisions ranging from which drugs a national formulary should cover to how much a society should invest in preventive care versus curative treatment. Health economists also study the determinants of health beyond clinical care, including socioeconomic status, education, environmental factors, and behavioral choices.

The field has grown in policy importance as countries around the world confront rising healthcare expenditures driven by aging populations, technological innovation, and the growing burden of chronic disease. Health economists contribute to debates on universal health coverage, pharmaceutical pricing, hospital payment reform, and the design of health insurance markets. Whether evaluating the Affordable Care Act in the United States, single-payer models in Canada and the United Kingdom, or social health insurance in Germany and Japan, health economics provides the analytical framework for understanding trade-offs among efficiency, equity, and quality in health systems.

You'll be able to:

  • Analyze cost-effectiveness ratios and quality-adjusted life years to evaluate competing healthcare interventions and resource allocation decisions
  • Apply demand elasticity and moral hazard concepts to predict consumer behavior under different health insurance structures
  • Evaluate market failures in healthcare delivery including information asymmetry, externalities, and the role of government regulation
  • Compare single-payer, multi-payer, and market-based healthcare financing models using efficiency and equity criteria

One step at a time.

Key Concepts

Quality-Adjusted Life Year (QALY)

A measure of disease burden that accounts for both the quality and quantity of life lived. One QALY equals one year of life in perfect health. QALYs allow comparison of interventions across different diseases by combining survival and health-related quality of life into a single index.

Example: A treatment that extends life by 2 years at a quality-of-life score of 0.5 yields 1.0 QALY, while a different treatment offering 1 year at full health also yields 1.0 QALY, making them equivalent by this measure.

Cost-Effectiveness Analysis (CEA)

An economic evaluation method that compares the relative costs and health outcomes of two or more interventions. Results are typically expressed as an incremental cost-effectiveness ratio (ICER), calculated as the difference in costs divided by the difference in health outcomes.

Example: If Drug A costs $50,000 and produces 3 QALYs while Drug B costs $30,000 and produces 2 QALYs, the ICER of Drug A relative to Drug B is ($50,000 - $30,000) / (3 - 2) = $20,000 per QALY gained.

Moral Hazard in Health Insurance

The tendency of insured individuals to consume more healthcare services than they would if they bore the full cost, because insurance reduces the out-of-pocket price at the point of care. This overconsumption can drive up premiums and total system costs.

Example: The RAND Health Insurance Experiment (1974-1982) found that people with free healthcare used roughly 30% more services than those with cost-sharing, yet for most people, the additional utilization did not improve health outcomes.

Adverse Selection

A market failure that occurs when individuals with higher health risks are more likely to purchase insurance than healthier individuals, leading to an insured pool that is sicker and more costly than the general population. This can cause a 'death spiral' of rising premiums.

Example: If a health insurer cannot distinguish between high-risk and low-risk applicants, it must charge an average premium. Healthy individuals may find this too expensive and drop out, leaving a sicker pool, which forces premiums even higher.

Health Technology Assessment (HTA)

A systematic evaluation of the properties, effects, and impacts of health technologies and interventions. HTA considers clinical effectiveness, cost-effectiveness, and broader social, ethical, and organizational implications to inform coverage and reimbursement decisions.

Example: The UK's National Institute for Health and Care Excellence (NICE) uses HTA to decide whether the National Health Service should fund new drugs, typically applying a willingness-to-pay threshold of 20,000 to 30,000 pounds per QALY.

Externalities in Health

Costs or benefits of health-related activities that affect third parties who are not directly involved in the transaction. Health externalities can be positive (vaccination protecting the unvaccinated through herd immunity) or negative (pollution causing respiratory disease in bystanders).

Example: When an individual gets vaccinated against measles, they not only protect themselves but also reduce the risk of transmission to infants too young to be vaccinated and immunocompromised individuals who cannot receive vaccines.

Elasticity of Demand for Healthcare

A measure of how responsive the quantity of healthcare demanded is to changes in price, income, or other factors. Healthcare demand tends to be relatively inelastic for emergency and life-saving services but more elastic for elective and preventive care.

Example: Studies consistently find that the price elasticity of demand for healthcare is around -0.2, meaning a 10% increase in out-of-pocket costs leads to roughly a 2% reduction in utilization on average.

Supplier-Induced Demand

A phenomenon in healthcare where providers, who possess more medical knowledge than patients, can influence the level of demand for their own services. Because patients rely on physicians for diagnosis and treatment recommendations, doctors may recommend more services than are strictly necessary.

Example: Research has shown that regions with more surgeons per capita tend to have higher rates of elective surgery, suggesting that the supply of physicians can independently influence the volume of procedures performed.

More terms are available in the glossary.

Explore your way

Choose a different way to engage with this topic β€” no grading, just richer thinking.

Explore your way β€” choose one:

Explore with AI β†’

Concept Map

See how the key ideas connect. Nodes color in as you practice.

Worked Example

Walk through a solved problem step-by-step. Try predicting each step before revealing it.

Adaptive Practice

This is guided practice, not just a quiz. Hints and pacing adjust in real time.

Small steps add up.

What you get while practicing:

  • Math Lens cues for what to look for and what to ignore.
  • Progressive hints (direction, rule, then apply).
  • Targeted feedback when a common misconception appears.

Teach It Back

The best way to know if you understand something: explain it in your own words.

Keep Practicing

More ways to strengthen what you just learned.

Health Economics Adaptive Course - Learn with AI Support | PiqCue